Tenapanor for peritoneal dialysis patients with hyperphosphatemia: a phase 3 trial.
Masaaki NakayamaShuhei KobayashiMiho KusakabeMeiko OharaKaoru NakanishiTadao AkizawaMasafumi FukagawaPublished in: Clinical and experimental nephrology (2023)
NCT04766385.